• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Merck Serono SA

SRA:US

Ticker Delisted

Snapshot for Merck Serono SA (SRA)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for SRA

No chart data available.
  • SRA:US
  • 1M
  • 1Y
0.0000
Interactive SRA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SRA

Current P/E Ratio (ttm) -
Estimated P/E(12/2007) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2007) -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 435.67
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.1663
Dividend Ex-Date 04/25/2006
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SRA

No data available

Company Profile & Key Executives for SRA

Merck Serono S.A. develops, manufactures, and markets biopharmaceutical products. The Company offers prescription medicines for prevention of cancer, neurodegenerative diseases, autoimmune and inflammatory diseases, infertility, endocrine and metabolic disorders, and cardiovascular diseases.

Belen Gurijo LopezPresident/CEO
More Company Profile & Key Executives for SRA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil